FGB 120
Natural health product licensed in Canada
- Other names
- Balancing Act, Femguard+Balance, Menopause Formula
- Licence holder
- Designs for Health Ltd.
- NPN or DIN-HM
- 80136056
- Status
- Active licence
- Licence date
- 15 November 2024
- Revision date
- 24 April 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-Diindolylméthane Source : 3,3'-diindolylméthane | 25 mg | Not calculated |
| Actaea racemosa Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Actaea racemosa Extract : Matériel brut sec Extraction ratio : 9:1 Dry plant equivalent : 225 mg | Not specified | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 7.5 mg | Not calculated |
| Folate Source : Acide L-5 méthyltétrahydrofolique, sel de glucosamine | 100 Microgrammes | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 100 Microgrammes | Not calculated |
| Vitex agnus-castus Source : Vitex agnus-castus - Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 mg Potency : 0.5 % Agnuside | 50 mg | Not calculated |
| 5,7-Dihydroxyflavone Source : Chrysine | 50 mg | Not calculated |
| Brassica oleracea var. italica Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 70 mg Potency : 13 % Glucoraphanin | 8.75 mg | Not calculated |
| Sinapis alba | 3.75 mg | Not calculated |
| trans-Resvératrol Source : Resvératrol | 5 mg | Not calculated |
| Magnésium Source : Malate de dimagnésium | 12.5 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg Potency : 45 % Epigallocatechin 3-gallate | 25 mg | Not calculated |
| Calcium Source : Saccharate de calcium | 12.5 mg | Not calculated |
Non-medicinal ingredients
Lécithine, Maltodextrine, Eau purifiée, Hypromellose, Cellulose microcristalline, Acide stéarique, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Used in Herbal Medicine to) help(s) relieve symptoms associated with menopause. Used in Herbal Medicine to help relieve premenstrual symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80136056
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.